Recombinant multi-species GYG1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GYG1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the glycogenin family. Glycogenin is a glycosyltransferase that catalyzes the formation of a short glucose polymer from uridine diphosphate glucose in an autoglucosylation reaction. This reaction is followed by elongation and branching of the polymer, catalyzed by glycogen synthase and branching enzyme, to form glycogen. This gene is expressed in muscle and other tissues. Mutations in this gene result in glycogen storage disease XV. This gene has pseudogenes on chromosomes 1, 8 and 13 respectively. Alternatively spliced transcript variants encoding different isoforms have been identified.[provided by RefSeq, Sep 2010]
The Alternative Names of target: GN-1,GN1,GSD15,GYG,GYG1,Glycogenin-1,Gyg,Gyg1
Go
to GYG1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP7856-Ag-1/ GM-Tg-hg-IP7856-Ag-2 | Human GYG1 protein | Human |
| GM-Tg-rg-IP7856-Ag-1/ GM-Tg-rg-IP7856-Ag-2 | Rat GYG1 protein | Rat |
| GM-Tg-mg-IP7856-Ag-1/ GM-Tg-mg-IP7856-Ag-2 | Mouse GYG1 protein | Mouse |
| GM-Tg-cynog-IP7856-Ag-1/ GM-Tg-cynog-IP7856-Ag-2 | Cynomolgus/Rhesus macaque GYG1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP7856-Ag-1/ GM-Tg-felg-IP7856-Ag-2 | Feline GYG1 protein | Feline |
| GM-Tg-cang-IP7856-Ag-1/ GM-Tg-cang-IP7856-Ag-2 | Canine GYG1 protein | Canine |
| GM-Tg-bovg-IP7856-Ag-1/ GM-Tg-bovg-IP7856-Ag-2 | Bovine GYG1 protein | Bovine |
| GM-Tg-equg-IP7856-Ag-1/ GM-Tg-equg-IP7856-Ag-2 | Equine GYG1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP7856-Ag-1/ GM-Tg-hg-IP7856-Ag-2;
GM-Tg-rg-IP7856-Ag-1/ GM-Tg-rg-IP7856-Ag-2;
GM-Tg-mg-IP7856-Ag-1/ GM-Tg-mg-IP7856-Ag-2; GM-Tg-cynog-IP7856-Ag-1/ GM-Tg-cynog-IP7856-Ag-2; GM-Tg-felg-IP7856-Ag-1/ GM-Tg-felg-IP7856-Ag-2; GM-Tg-cang-IP7856-Ag-1/ GM-Tg-cang-IP7856-Ag-2; GM-Tg-bovg-IP7856-Ag-1/ GM-Tg-bovg-IP7856-Ag-2; GM-Tg-equg-IP7856-Ag-1/ GM-Tg-equg-IP7856-Ag-2 |
| Products Name | GYG1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | GYG1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine GYG1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.